Raymond James Trust’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $389K | Buy |
2,669
+1,113
| +72% | +$161K | 0.01% | 911 |
|
|
2024
Q2 | $214K | Sell |
1,556
-50
| -3% | -$6.67K | 0.01% | 1162 |
|
|
2024
Q1 | $220K | Buy |
1,606
+55
| +4% | +$7.51K | 0.01% | 1143 |
|
|
2023
Q4 | $211K | Sell |
1,551
-532
| -26% | -$64.9K | 0.01% | 1113 |
|
|
2023
Q3 | $255K | Sell |
2,083
-300
| -13% | -$38.2K | 0.01% | 964 |
|
|
2023
Q2 | $303K | Buy |
2,383
+144
| +6% | +$18.7K | 0.01% | 890 |
|
|
2023
Q1 | $289K | Buy |
2,239
+50
| +2% | +$6.54K | 0.01% | 879 |
|
|
2022
Q4 | $287K | Sell |
2,189
-144
| -6% | -$18.6K | 0.01% | 849 |
|
|
2022
Q3 | $273K | Buy |
2,333
+9
| +0.4% | +$1.12K | 0.01% | 831 |
|
|
2022
Q2 | $273K | Buy |
2,324
+28
| +1% | +$3.32K | 0.01% | 843 |
|
|
2022
Q1 | $299K | Buy |
2,296
+11
| +0.5% | +$1.43K | 0.01% | 881 |
|
|
2021
Q4 | $349K | Sell |
2,285
-18
| -0.8% | -$2.79K | 0.01% | 817 |
|
|
2021
Q3 | $372K | Buy |
2,303
+288
| +14% | +$48.5K | 0.01% | 746 |
|
|
2021
Q2 | $330K | Hold |
2,015
| – | – | 0.01% | 816 |
|
|
2021
Q1 | $303K | Sell |
2,015
-43
| -2% | -$6.83K | 0.01% | 822 |
|
|
2020
Q4 | $312K | Sell |
2,058
-938
| -31% | -$134K | 0.01% | 754 |
|
|
2020
Q3 | $406K | Buy |
2,996
+512
| +21% | +$69.5K | 0.02% | 562 |
|
|
2020
Q2 | $340K | Buy |
+2,484
| New | +$317K | 0.02% | 604 |
|
|
2018
Q4 | – | Sell |
-1,801
| Closed | -$219K | – | 868 |
|
|
2018
Q3 | $219K | Buy |
+1,801
| New | +$212K | 0.01% | 775 |
|
|
2018
Q2 | – | Sell |
-2,435
| Closed | -$260K | – | 868 |
|
|
2018
Q1 | $260K | Sell |
2,435
-55
| -2% | -$6.1K | 0.02% | 576 |
|
|
2017
Q4 | $265K | Buy |
2,490
+54
| +2% | +$5.77K | 0.02% | 579 |
|
|
2017
Q3 | $271K | Buy |
+2,436
| New | +$260K | 0.02% | 574 |
|
|
2017
Q1 | – | Sell |
-2,943
| Closed | -$260K | – | 723 |
|
|
2016
Q4 | $260K | Buy |
+2,943
| New | +$268K | 0.02% | 529 |
|
|
2016
Q1 | – | Sell |
-1,806
| Closed | -$204K | – | 694 |
|
|
2015
Q4 | $204K | Buy |
+1,806
| New | +$196K | 0.02% | 607 |
|
|
2015
Q3 | – | Sell |
-1,806
| Closed | -$222K | – | 634 |
|
|
2015
Q2 | $222K | Buy |
+1,806
| New | +$216K | 0.02% | 543 |
|
|
2014
Q1 | – | Sell |
-5,100
| Closed | -$386K | – | 596 |
|
|
2013
Q4 | $386K | Sell |
5,100
-150
| -3% | -$10.6K | 0.05% | 321 |
|
|
2013
Q3 | $367K | Hold |
5,250
| – | – | 0.06% | 307 |
|
|
2013
Q2 | $304K | Buy |
+5,250
| New | +$303K | 0.05% | 329 |
|
Other funds holding IBB
CB
Raymond James Trust's IBB Position: Q3 2024 in Review
Raymond James Trust increased its iShares Biotechnology ETF (IBB) stake by 72% in Q3 2024, buying an estimated $161K and bringing the position to 2,669 shares worth $389K. The position accounts for 0.01% of the portfolio, ranked #911.
Raymond James Trust first reported a position in IBB in Q2 2013 and has held it in 28 quarters since. The position peaked at $406K in Q3 2020. 893 funds tracked by Wall St. Rank hold IBB as of Q3 2024.
- Raymond James Trust held 2,669 shares of iShares Biotechnology ETF worth $389K as of Q3 2024.
- Raymond James Trust bought 1,113 iShares Biotechnology ETF shares in Q3 2024, an estimated $161K.
- iShares Biotechnology ETF made up 0.01% of Raymond James Trust's portfolio in Q3 2024, its #911 holding.
- Raymond James Trust first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 28 quarters since.
- Raymond James Trust's iShares Biotechnology ETF position peaked at $406K in Q3 2020.
- 893 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2024.
Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.